Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Best Growth Stocks to Buy for January 21st

Published 01/21/2022, 07:28 AM
Updated 07/09/2023, 06:31 AM

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 21st:

Pfizer PFE: This company that manufactures, markets, distributes, and sells biopharmaceutical products carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.

Pfizer Inc. (NYSE:PFE) Price and Consensus

Pfizer Inc. price-consensus-chart | Pfizer Inc. Quote

Pfizer has a PEG ratio of 0.75 compared with 1.72 for the industry. The company possesses a Growth Score of B.

Pfizer Inc. PEG Ratio (TTM)

Pfizer Inc. peg-ratio-ttm | Pfizer Inc. Quote

Macy's (NYSE:M) M: This omnichannel retail organization carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.3% over the last 60 days.

Macy's has a PEG ratio of 0.41 compared with 0.54 for the industry. The company possesses a Growth Score of B.

Macy's, Inc. PEG Ratio (TTM)

Macy's, Inc. peg-ratio-ttm | Macy's, Inc. Quote

ArcBest (NASDAQ:ARCB) ARCB: This company that provides freight transportation services and solutions carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1% over the last 60 days.

ArcBest has a PEG ratio of 0.21 compared with 0.76 for the industry. The company possesses a Growth Score of A.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.


5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Pfizer Inc. (PFE): Free Stock Analysis Report

Macy's, Inc. (M): Free Stock Analysis Report

ArcBest Corporation (ARCB): Free Stock Analysis Report

To read this article on Zacks.com click here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.